CAS 209860-87-7

Tafluprost

Description:

Tafluprost is a synthetic prostaglandin analog primarily used in ophthalmology for the treatment of glaucoma and ocular hypertension. It functions by increasing the outflow of aqueous humor, thereby reducing intraocular pressure. The chemical structure of Tafluprost includes a carboxylic acid group and a fluorinated alkyl chain, which contribute to its potency and selectivity for the prostaglandin FP receptor. It is typically administered as an eye drop solution and is known for its long-lasting effects, often requiring once-daily dosing. Tafluprost is characterized by its stability under various conditions, making it suitable for pharmaceutical formulations. Common side effects may include conjunctival hyperemia, eyelash growth, and changes in iris pigmentation. Its efficacy and safety profile have made it a valuable option in the management of glaucoma, particularly for patients who may not respond adequately to other treatments. As with any medication, it is essential for patients to follow their healthcare provider's instructions and report any adverse effects.

Formula: C₂₅H₃₄F₂O₅

InChI: InChI=1/C25H34F2O5/c1-18(2)32-24(30)13-9-4-3-8-12-20-21(23(29)16-22(20)28)14-15-25(26,27)17-31-19-10-6-5-7-11-19/h3,5-8,10-11,14-15,18,20-23,28-29H,4,9,12-13,16-17H2,1-2H3/b8-3+,15-14+

InChI key: InChIKey=WSNODXPBBALQOF-VEJSHDCNSA-N

SMILES: C(/C=C\CCCC(OC(C)C)=O)[C@@H]1[C@@H](/C=C/C(COC2=CC=CC=C2)(F)F)[C@H](O)C[C@@H]1O

Synonyms:

• (5Z)-7-[(1R,2R,3R,5S)-2-[(1E)-3,3-Difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-5-heptenoic acid 1-methylethyl ester
• 1-methylethyl (5E)-7-{2-[(1E)-3,3-difluoro-4-phenoxybut-1-en-1-yl]-3,5-dihydroxycyclopentyl}hept-5-enoate
• 5-Heptenoic acid, 7-[(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-, 1-methylethyl ester, (5Z)-
• 5-Heptenoic acid, 7-[(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxy-1-butenyl]-3,5-dihydroxycyclopentyl]-, 1-methylethyl ester, (5Z)-
• Afp 168
• Mk 2452
• Saflutan
• Taflotan
• Tapros
• Ziotan
• Tafluprost
• Tafluprost Q: What is the storage condition of
• Tafluprosttrade
• He has fluprostaglandin
• Isopropyl (Z)-7-[(1R,2R,3R,5S)-2-[(E)-3,3-Difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-5-heptenoate
• MK2452
• uprost
• Tafluprost Q: What is the CAS Number of
• (Z)-Isopropyl 7-((1R,2R,3R,5S)-2-((E)-3,3-difluoro-4-phenoxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoate
• Tafluprost5-Heptenoic acid, 7-[(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-,1-methylethyl ester, (5Z)-
• 15,15-DIFLUORO-9ALPHA,11ALPHA-DIHYDROXY-16-PHENOXY-17,18,19,20-TETRANOR-PROSTA-5Z,13E-DIEN-1-OIC ACID, ISOPROPYL ESTER
• Tafluprost USP/EP/BP
• 209860-87-7 Tafluprost
• TafluprostQ: What is
• Tafluprost Q: What are the applications of
• aflupros

5-Heptenoic acid, 7-[(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-, 1-methylethyl ester, (5Z)-

CAS: 209860-87-7

Formula: C₂₅H₃₄F₂O₅

Purity: 97%

Color and Shape: Liquid

Molecular weight: 452.5313

Ref: IN-DA002KG9

(Z)-Isopropyl 7-((1R,2R,3R,5S)-2-((E)-3,3-Difluoro-4-Phenoxybut-1-En-1-Yl)-3,5-Dihydroxycyclopentyl)Hept-5-Enoate

CAS: 209860-87-7

(Z)-Isopropyl 7-((1R,2R,3R,5S)-2-((E)-3,3-Difluoro-4-Phenoxybut-1-En-1-Yl)-3,5-Dihydroxycyclopentyl)Hept-5-Enoate

Purity: 97%

Molecular weight: 452.53g/mol

Ref: 54-PC108666

Tafluprost

CAS: 209860-87-7

Formula: C₂₅H₃₄F₂O₅

Molecular weight: 452.54

Ref: 4Z-T-486001

Tafluprost (0.10% wt/v in ETHANOL), min. 98%

CAS: 209860-87-7

Formula: C₂₅H₃₄F₂O₅

Purity: min. 98%

Color and Shape: Colorless to Yellowish Oil (SOLUTION IN 10% ETHANOL)

Molecular weight: 452.53

Ref: 08-06-6001

Tafluprost

CAS: 209860-87-7

Tafluprost

Purity: ≥95%

Molecular weight: 452.53g/mol

Ref: 54-BUP08801

Tafluprost

Controlled Product

CAS: 209860-87-7

Formula: C₂₅H₃₄F₂O₅

Color and Shape: Neat

Molecular weight: 452.53

Ref: 04-CA17134000

Tafluprost

CAS: 209860-87-7

Tafluprost, a prostaglandin analog, is the selective agonist of fluoroprostaglandin (FP) receptor PGF2α.

Formula: C₂₅H₃₄F₂O₅

Purity: 97.7% - 99.67%

Color and Shape: Liquid

Molecular weight: 452.53

Ref: TM-TQ0203

Tafluprost

Controlled Product

CAS: 209860-87-7

Applications Tafluprost is a novel prostanoid used in the treatment of glaucoma and is the first prostanoid to be released in a preservative free-formula.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Kaplowitz, K., et al.: Exp. Rev. Ophthalmol., 7, 401 (2012); Abe, S., et al.: J. Ocular. Pharmacol. Therap., 29, 55 (2013);

Formula: C₂₅H₃₄F₂O₅

Color and Shape: Colourless To Light Yellow

Molecular weight: 452.53

Ref: TR-T004820

Tafluprost

CAS: 209860-87-7

Prostanoid receptor agonist

Formula: C₂₅H₃₄F₂O₅

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 452.53 g/mol

Ref: 3D-FT103897

TAFLUPROST

CAS: 209860-87-7

Purity: 98%

Molecular weight: 452.5390015

Ref: 10-F811906

epi-Tafluprost

Controlled Product

CAS: 209860-87-7

Formula: C₂₅H₃₄F₂O₅

Color and Shape: Neat

Molecular weight: 452.531

Ref: TR-T004830

Tafluprost

CAS: 209860-87-7

Formula: C₂₅H₃₄F₂O₅

Color and Shape: Pale Yellow Liquid

Molecular weight: 452.54

Ref: 4Z-L-3213